Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

Part of paid clinical trials in Greenwich, Connecticut.

Sponsor
Yale University
Study ID
NCT04210492
Phase
PHASE1/PHASE2
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • 45 Gray (Gy) regimen — RADIATION
    Deescalated 3-fraction stereotactic body radiotherapy regimen to 45 Gy in 3 fractions.

Study Details

The purpose of this trial is to test a deescalated 3-fraction stereotactic body radiotherapy (SBRT) regimen to 45 Gray (Gy) in 3 fractions for centrally located thoracic tumors.

Key Dates

Start date
Aug 26, 2020
Status verified
Jun 2026
Primary completion
Jan 31, 2030
Completion
Jan 31, 2030

Study Design

Enrollment
36 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: 45 Gy
    Deescalated 3-fraction stereotactic body radiotherapy regimen to 45 Gy in 3 fractions.

Primary Outcome Measure

Safety of the stereotactic body radiotherapy regimen (SBRT) [ Time Frame: From administration of SBRT up to 2 years post-SBRT ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Smilow Cancer Hospital Care Center at GreenwichGreenwichConnecticut06830
Jennifer Pope
203-494-3732
Smilow Cancer Hospital Care Center - GuilfordGuilfordConnecticut06437
Jennifer Pope
203-494-3732
Smilow Cancer Hospital - Hamden Care CenterHamdenConnecticut06518
Jennifer Pope
203-494-3732
Smilow Cancer HospitalNew HavenConnecticut06511
Jennifer Pope
203-494-3732
Smilow Cancer Hospital Care Center - TrumbullTrumbullConnecticut06611
Jennifer Pope
203-494-3732
Smilow Cancer Hospital Care Center - WaterfordWaterfordConnecticut06385
Jennifer Pope
203-494-3732

Find similar trials in Greenwich, CT

By condition

Related Studies